Rezolute, Inc. - Common Stock (RZLT)

Historical Holders from Q4 2020 to Q4 2025

Symbol
RZLT on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
92,696,226
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
86,920,142
Holdings value
$817,052,884
% of all portfolios
0.01%
Number of holders
115
Number of buys
74
Number of sells
39
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rezolute, Inc. - Common Stock (RZLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $140,627,089 15,302,186 RA Capital Healthcare Fund, L.P. 11 Dec 2025
FMR LLC 15% +41% $47,019,585 +$23,675,056 12,811,876 +101% FMR LLC 30 Jun 2025
Opaleye Management Inc. 5.3% $45,149,551 4,912,900 Opaleye Management Inc. 12 Dec 2025
BlackRock, Inc. 5.4% $45,886,185 4,881,509 BlackRock, Inc. 30 Sep 2025
Invus Global Management, LLC 5.4% $34,090,000 4,870,000 Raymond Debbane 18 Sep 2025
Nantahala Capital Management, LLC 4.9% -41% $8,288,148 -$6,115,332 2,857,982 -42% Nantahala Capital Management, LLC 31 Dec 2024
As of 30 Sep 2025 Rezolute, Inc. - Common Stock (RZLT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 86,920,142 shares of 92,696,226 outstanding shares and own 94% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Rezolute, Inc. - Common Stock (RZLT) own 84% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
FEDERATED HERMES, INC. 15% $131,926,293 14,034,712 0%
FMR LLC 14% $119,983,791 12,764,233 -0.37%
BlackRock, Inc. 5.4% $47,041,697 5,004,436 +23%
Siren, L.L.C. 5.3% $45,778,000 4,870,000
VANGUARD GROUP INC 4.8% $41,454,771 4,410,082 +9.6%
Blackstone Inc. 3.3% $28,424,651 3,023,899 -15%
MANGROVE PARTNERS IM, LLC 3.1% $27,092,201 2,882,149 +25%
MARSHALL WACE, LLP 2.9% $25,646,160 2,728,315 -5.5%
UBS Group AG 2.9% $25,342,193 2,695,978 -11%
GREAT POINT PARTNERS LLC 2.6% $23,047,005 2,451,809 -19%
Vivo Capital, LLC 2.3% $19,856,861 2,112,432 0%
Affinity Asset Advisors, LLC 2.3% $19,740,000 2,100,000 -4.5%
STATE STREET CORP 2.3% $19,659,874 2,091,476 +152%
Integral Health Asset Management, LLC 2.2% $18,800,000 2,000,000 +11%
CAXTON CORP 2.1% $18,676,089 1,986,818 +24%
GEODE CAPITAL MANAGEMENT, LLC 2% $17,369,547 1,847,384 +8%
Balyasny Asset Management L.P. 2% $17,133,643 1,822,728
Rosalind Advisors, Inc. 1.9% $16,987,698 1,807,202 +3.8%
BANK OF AMERICA CORP /DE/ 1.4% $12,078,642 1,284,962 +1579%
Point72 Asset Management, L.P. 1.2% $10,879,651 1,157,410 +447%
Woodline Partners LP 1% $8,825,134 938,844 -51%
STEMPOINT CAPITAL LP 0.99% $8,625,722 917,630 +42%
Opaleye Management Inc. 0.97% $8,492,355 903,442 0%
22NW, LP 0.89% $7,714,138 820,653
ADAR1 Capital Management, LLC 0.88% $7,670,165 815,975 -18%

Institutional Holders of Rezolute, Inc. - Common Stock (RZLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 15 $35 +$35 $2.33 1
2025 Q3 86,920,142 $817,052,884 +$108,361,486 $9.40 115
2025 Q2 77,913,169 $347,492,575 +$151,536,991 $4.46 91
2025 Q1 45,040,344 $130,615,009 -$811,008 $2.90 76
2024 Q4 43,207,187 $211,713,139 +$30,093,703 $4.90 71
2024 Q3 38,544,894 $186,942,117 -$3,938,832 $4.85 59
2024 Q2 39,525,913 $169,961,526 +$54,178,979 $4.30 51
2024 Q1 27,042,621 $68,962,251 +$246,855 $2.55 33
2023 Q4 28,952,301 $28,740,703 +$4,794,203 $0.9925 31
2023 Q3 23,889,501 $31,534,322 -$458,983 $1.32 29
2023 Q2 24,223,878 $47,962,915 +$49,685 $1.98 28
2023 Q1 24,226,408 $46,514,454 -$475,671 $1.92 31
2022 Q4 24,450,852 $50,611,801 +$2,511,816 $2.07 34
2022 Q3 1,407,290 $3,857,000 -$122 $3.97 2
2022 Q2 0 $0 -$2,000 0
2022 Q1 7,085,710 $23,951,000 -$2,289,057 $3.38 19
2021 Q4 7,529,707 $35,989,000 +$22,778,301 $4.78 21
2021 Q3 2,373,215 $17,647,000 +$1,206,769 $7.48 13
2021 Q2 2,211,492 $31,558,000 -$1,377,630 $14.27 11
2021 Q1 2,477,026 $17,487,000 -$208,256 $7.06 10
2020 Q4 2,506,346 $30,230,000 +$30,230,001 $11.99 7